{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:03Z","timestamp":1790888703260,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S. with over 80 million infected individuals. High-risk strains are associated with 6 different cancers. Although infection is preventable, U.S. vaccination rates remain suboptimal and there are noted disparities between urban and rural communities due to economic barriers, lack of access, and low awareness and education.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The current pilot study sought to overcome these barriers through an interprofessional collaborative enrolling a community pharmacy in a rural, medically underserved Alabama county as a Vaccines for Children (VFC) provider to provide free vaccines to eligible adolescents. Program evaluation was conducted to determine the intervention\u2019s feasibility. Potential efficacy was assessed by analyzing county-level HPV vaccination uptake and completion rates using state immunization registry data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over the 8-month study, 166 total vaccines were administered to 89 adolescents ages 10\u201318, including 55 doses of HPV vaccine, 53 doses of Tdap vaccine, 45 doses of meningococcal vaccine, and 13 doses of influenza vaccine. Among these adolescents, mean age was 12.6\u2009years old, and 64 (71.9%) were VFC patients. The pharmacy recorded an increase in total vaccine administration of 158.8%, an increase in prescription revenue of 34.8%, and an increase in total revenue by 24.4% during the course of the study, compared to the previous year.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings from the current work demonstrate the potential of this strategy and can serve as a blueprint for statewide and national dissemination and implementation to ultimately increase access to vaccination services, increase vaccination rates, and reduce urban-rural vaccine disparities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11304-8","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T18:02:48Z","timestamp":1624989768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Enrolling a rural community pharmacy as a Vaccines for Children provider to increase HPV vaccination: a feasibility study"],"prefix":"10.1186","volume":"21","author":[{"given":"Casey L.","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macy","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamera","family":"Coyne-Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie","family":"Turberville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"11304_CR1","volume-title":"HPV and cancer","author":"CDC","year":"2019","unstructured":"CDC. HPV and cancer. 2019; https:\/\/www.cdc.gov\/cancer\/hpv\/statistics\/index.htm. Accessed 18 Jan 2020."},{"key":"11304_CR2","volume-title":"Human Papillomavirus (HPV)","author":"CDC","year":"2019","unstructured":"CDC. Human Papillomavirus (HPV). 2019; https:\/\/www.cdc.gov\/hpv\/parents\/about-hpv.html. Accessed 4 Nov 2020."},{"key":"11304_CR3","volume-title":"Immunizations and infectious diseases","author":"2020 HP","year":"2020","unstructured":"2020 HP. Immunizations and infectious diseases. 2020; https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives. Accessed 20 Jan 2021."},{"key":"11304_CR4","volume-title":"HPV vaccination uptake","author":"C Australia","year":"2019","unstructured":"Australia C. HPV vaccination uptake. 2019; https:\/\/ncci.canceraustralia.gov.au\/prevention\/hpv-vaccination-uptake\/hpv-vaccination-uptake. Accessed 20 Jan 2021."},{"issue":"24","key":"11304_CR5","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1016\/j.vaccine.2012.03.063","volume":"30","author":"SJ Kessels","year":"2012","unstructured":"Kessels SJ, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546\u201356. https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.063.","journal-title":"Vaccine."},{"key":"11304_CR6","doi-asserted-by":"publisher","unstructured":"Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197\u2013204. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181f12dbf.","DOI":"10.1097\/OLQ.0b013e3181f12dbf"},{"issue":"4","key":"11304_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.vaccine.2009.10.133","volume":"28","author":"A Dempsey","year":"2010","unstructured":"Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine. 2010;28(4):989\u201395. https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.133.","journal-title":"Vaccine."},{"issue":"4","key":"11304_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/jrh.12408","volume":"36","author":"CL Daniel","year":"2020","unstructured":"Daniel CL, Wright AR. Increasing HPV vaccination in rural settings: the hidden potential of community pharmacies. J Rural Health. 2020;36(4):465\u20137. https:\/\/doi.org\/10.1111\/jrh.12408.","journal-title":"J Rural Health"},{"issue":"3","key":"11304_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jadohealth.2017.05.016","volume":"61","author":"NA Vielot","year":"2017","unstructured":"Vielot NA, Butler AM, Brookhart MA, Becker-Dreps S, Smith JS. Patterns of use of human papillomavirus and other adolescent vaccines in the United States. J Adolesc Health. 2017;61(3):281\u20137. https:\/\/doi.org\/10.1016\/j.jadohealth.2017.05.016.","journal-title":"J Adolesc Health"},{"key":"11304_CR10","volume-title":"What is rural America?","author":"U Census","year":"2017","unstructured":"Census U. What is rural America? 2017; https:\/\/www.census.gov\/library\/stories\/2017\/08\/rural-america.html. Accessed 21 Aug 2019."},{"issue":"4","key":"11304_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jrh.12353","volume":"35","author":"AL Swiecki-Sikora","year":"2019","unstructured":"Swiecki-Sikora AL, Henry KA, Kepka D. HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health. 2019;35(4):506\u201317. https:\/\/doi.org\/10.1111\/jrh.12353.","journal-title":"J Rural Health."},{"key":"11304_CR12","doi-asserted-by":"crossref","unstructured":"Koskan AM, Dominick LN, Helitzer DL. Rural caregivers\u2019 willingness for community pharmacists to administer the HPV vaccine to their age-eligible children. J Cancer Educ. 2021;36(1):189\u201398.","DOI":"10.1007\/s13187-019-01617-z"},{"key":"11304_CR13","doi-asserted-by":"publisher","DOI":"10.5888\/pcd17.190351","volume":"17","author":"G Ryan","year":"2020","unstructured":"Ryan G, Daly E, Askelson N, Pieper F, Seegmiller L, Allred T. Exploring opportunities to leverage pharmacists in rural areas to promote administration of human papillomavirus vaccine. Prev Chronic Dis. 2020;17:E23.","journal-title":"Prev Chronic Dis"},{"issue":"7\u20138","key":"11304_CR14","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1080\/21645515.2018.1553475","volume":"15","author":"RC Vanderpool","year":"2019","unstructured":"Vanderpool RC, Stradtman LR, Brandt HM. Policy opportunities to increase HPV vaccination in rural communities. Hum Vaccines Immunother. 2019;15(7\u20138):1527\u201332. https:\/\/doi.org\/10.1080\/21645515.2018.1553475.","journal-title":"Hum Vaccines Immunother."},{"key":"11304_CR15","unstructured":"HPV vaccination for cancer prevention: Progress, opportunities, and a renewd call to action. A report to the President of the United States from the Chair of the President's Cancer Panel. Bethesda: President's Cancer Panel; 2018. https:\/\/prescancerpanel.cancer.gov\/report\/hpvupdate."},{"issue":"8","key":"11304_CR16","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1080\/21645515.2017.1325980","volume":"13","author":"JP Fava","year":"2017","unstructured":"Fava JP, Colleran J, Bignasci F, Cha R, Kilgore PE. Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccines Immunother. 2017;13(8):1844\u201355. https:\/\/doi.org\/10.1080\/21645515.2017.1325980.","journal-title":"Hum Vaccines Immunother."},{"issue":"Suppl 1","key":"11304_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ygyno.2013.12.020","volume":"132","author":"NT Brewer","year":"2014","unstructured":"Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS. Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol. 2014;132(Suppl 1):S3\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.020.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"11304_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1586\/14760584.2013.871204","volume":"13","author":"PD Shah","year":"2014","unstructured":"Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014;13(2):235\u201346. https:\/\/doi.org\/10.1586\/14760584.2013.871204.","journal-title":"Expert Rev Vaccines"},{"issue":"Rr-1","key":"11304_CR19","first-page":"1","volume":"49","author":"AS Postema","year":"2000","unstructured":"Postema AS, Breiman RF. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep. 2000;49(Rr-1):1\u201313.","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"11304_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1370\/afm.1542","volume":"11","author":"JA Goad","year":"2013","unstructured":"Goad JA, Taitel MS, Fensterheim LE, Cannon AE. Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med. 2013;11(5):429\u201336. https:\/\/doi.org\/10.1370\/afm.1542.","journal-title":"Ann Fam Med"},{"key":"11304_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/IPRP.S63822","volume":"4","author":"AT Bach","year":"2015","unstructured":"Bach AT, Goad JA. The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integr Pharm Res Pract. 2015;4:67\u201377. https:\/\/doi.org\/10.2147\/IPRP.S63822.","journal-title":"Integr Pharm Res Pract"},{"issue":"2","key":"11304_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1331\/JAPhA.2010.09168","volume":"50","author":"T Pilisuk","year":"2010","unstructured":"Pilisuk T, Goad J, Backer H. Vaccination delivery by chain pharmacies in California: results of a 2007 survey. J Am Pharm Assoc. 2010;50(2):134\u20139. https:\/\/doi.org\/10.1331\/JAPhA.2010.09168.","journal-title":"J Am Pharm Assoc."},{"issue":"3","key":"11304_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/1468-0009.12342","volume":"96","author":"PD Shah","year":"2018","unstructured":"Shah PD, Trogdon JG, Golden SD, Golin CE, Marciniak MW, Brewer NT. Impact of pharmacists on access to vaccine providers: a geospatial analysis. Milbank Q. 2018;96(3):568\u201392. https:\/\/doi.org\/10.1111\/1468-0009.12342.","journal-title":"Milbank Q"},{"key":"11304_CR24","volume-title":"National Adult Immunization Plan (NAIP)","author":"NVP Office","year":"2016","unstructured":"Office NVP. National Adult Immunization Plan (NAIP). Washington, DC: United States Department of Health and Human Services; 2016."},{"key":"11304_CR25","doi-asserted-by":"publisher","unstructured":"Calo WA, Shah PD, Gilkey MB, Vanderpool RC, Barden S, Doucette WR, et al. Implementing pharmacy-located HPV vaccination: findings from pilot projects in five U.S. states. Hum Vaccines Immunother. 2019;15(7\u20138):1831\u20138. https:\/\/doi.org\/10.1080\/21645515.2019.1602433.","DOI":"10.1080\/21645515.2019.1602433"},{"key":"11304_CR26","volume-title":"State-level projections of supply and demand for primary care practitioners: 2013\u20132015","author":"HRSA","year":"2016","unstructured":"HRSA. In: Services USDoHaH, editor. State-level projections of supply and demand for primary care practitioners: 2013\u20132015; 2016."},{"key":"11304_CR27","volume-title":"Social determinants of health for rural people","author":"RHIhub","year":"2019","unstructured":"RHIhub. Social determinants of health for rural people. 2019; https:\/\/www.ruralhealthinfo.org\/topics\/social-determinants-of-health. Accessed 20 Jan 2021."},{"key":"11304_CR28","volume-title":"Rural America at a glance: 2018 edition","author":"Service ER","year":"2018","unstructured":"Service ER. In: Agriculture USDo, editor. Rural America at a glance: 2018 edition; 2018."},{"key":"11304_CR29","volume-title":"Vaccines for Children Program (VFC)","author":"CDC","year":"2016","unstructured":"CDC. Vaccines for Children Program (VFC). 2016; https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/index.html. Accessed 16 Nov 2020."},{"issue":"6","key":"11304_CR30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s10900-019-00690-1","volume":"44","author":"M Vickers","year":"2019","unstructured":"Vickers M, Green CL, Lee HY, Pierce JY, Daniel CL. Factors associated with HPV vaccination uptake and HPV-associated cancers: a county-level analysis in the state of Alabama. J Community Health. 2019;44(6):1214\u201323. https:\/\/doi.org\/10.1007\/s10900-019-00690-1.","journal-title":"J Community Health"},{"key":"11304_CR31","volume-title":"Rural-urban continuum codes","author":"Service ER","year":"2013","unstructured":"Service ER. Rural-urban continuum codes. 2013. Accessed 21 Jan 2021."},{"key":"11304_CR32","volume-title":"Area health resources files","author":"Warehouse HRaSAD","year":"2016","unstructured":"Warehouse HRaSAD. Area health resources files. 2016; https:\/\/data.hrsa.gov\/topics\/health-workforce\/ahrf. Accessed 27 Aug 2018."},{"key":"11304_CR33","volume-title":"Current VFC providers","author":"ADPH","year":"2018","unstructured":"ADPH. Current VFC providers. 2018; https:\/\/www.alabamapublichealth.gov\/immunization\/assets\/currentvfcproviders.pdf. Accessed 21 Jan 2021."},{"key":"11304_CR34","volume-title":"Immunization patient resources with integrated technology (ImmPRINT)","author":"ADPH","year":"2018","unstructured":"ADPH. Immunization patient resources with integrated technology (ImmPRINT). 2018; https:\/\/siis.state.al.us\/ImmPrint\/login\/login.aspx. Accessed 10 Jan 2021."},{"key":"11304_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/109019817400200401","volume":"2","author":"MH Becker","year":"1974","unstructured":"Becker MH. The health belief model and personal health behavior. Health Educ Monogr. 1974;2:324\u2013473.","journal-title":"Health Educ Monogr"},{"key":"11304_CR36","volume-title":"Vaccine recommendations and guidelines of the ACIP","author":"ACIP","year":"2017","unstructured":"ACIP. Vaccine recommendations and guidelines of the ACIP. 2017; https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/programs.html, 2018."},{"key":"11304_CR37","unstructured":"County Health Rankings & Roadmaps. 2018; http:\/\/www.countyhealthrankings.org\/rankings\/data\/al. Accessed 23 Sep 2018."},{"key":"11304_CR38","volume-title":"QuickFacts: Clarke County, Alabama","author":"Bureau USC","year":"2018","unstructured":"Bureau USC. QuickFacts: Clarke County, Alabama. 2018; https:\/\/www.census.gov\/quickfacts\/clarkecountyalabama. Accessed 3 Jan 2021."},{"key":"11304_CR39","volume-title":"Alabama medicaid analytics","author":"Medicaid A","year":"2018","unstructured":"Medicaid A. Alabama medicaid analytics. 2018; https:\/\/public.tableau.com\/profile\/medicaid.analytics#!\/. Accessed 10 Jan 2021."},{"key":"11304_CR40","unstructured":"Review WP. Grove Hill, Alabama Population 2018; https:\/\/worldpopulationreview.com\/us-cities\/grove-hill-al-population. Accessed 10 Jan 2021."},{"key":"11304_CR41","volume-title":"Vaccination roundtable pharmacy-located HPV vaccination pilot project","author":"S Barden","year":"2018","unstructured":"Barden S, National HPV. Vaccination roundtable pharmacy-located HPV vaccination pilot project; 2018."},{"issue":"4","key":"11304_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.vaccine.2019.11.028","volume":"38","author":"MA Gerend","year":"2020","unstructured":"Gerend MA, Murdock C, Grove K. An intervention for increasing HPV vaccination on a university campus. Vaccine. 2020;38(4):725\u20139.","journal-title":"Vaccine."},{"issue":"6","key":"11304_CR43","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1370\/afm.1188","volume":"8","author":"JD Nordin","year":"2010","unstructured":"Nordin JD, Solberg LI, Parker ED. Adolescent primary care visit patterns. Ann Fam Med. 2010;8(6):511\u20136. https:\/\/doi.org\/10.1370\/afm.1188.","journal-title":"Ann Fam Med"},{"issue":"7","key":"11304_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.9132","volume":"3","author":"LA Berenbrok","year":"2020","unstructured":"Berenbrok LA, Gabriel N, Coley KC, Hernandez I. Evaluation of frequency of encounters with primary care physicians vs visits to community pharmacies among medicare beneficiaries. JAMA Netw Open. 2020;3(7):e209132. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.9132.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"11304_CR45","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1331\/JAPhA.2014.13222","volume":"54","author":"JP Navarrete","year":"2014","unstructured":"Navarrete JP, Padilla ME, Castro LP, Rivera JO. Development of a community pharmacy human papillomavirus vaccine program for underinsured university students along the United States\/Mexico border. J Am Pharm Assoc. 2014;54(6):642\u20137. https:\/\/doi.org\/10.1331\/JAPhA.2014.13222.","journal-title":"J Am Pharm Assoc"},{"issue":"8","key":"11304_CR46","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1158\/1055-9965.EPI-18-0380","volume":"27","author":"PD Shah","year":"2018","unstructured":"Shah PD, Calo WA, Marciniak MW, Gilkey MB, Brewer NT. Support for pharmacist-provided HPV vaccination: National Surveys of U.S. physicians and parents. Cancer Epidemiol, Biomarkers Prev. 2018;27(8):970\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0380.","journal-title":"Cancer Epidemiol, Biomarkers Prev"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11304-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11304-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T18:03:37Z","timestamp":1624989817000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11304-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11304"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11304-8","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients were not directly contacted, nor was identifying information collected regarding those vaccinated. All data on vaccination uptake was aggregate and de-identified. Qualitative interviews were conducted via key informant interviews and anonymous polling. Consent was obtained when applicable. As a study collaborator, the pharmacist involved with the project was not required to complete formal consent. All methods were carried out in accordance with relevant guidelines and regulations. The University of South Alabama Institutional Review Board approved the study protocol presented here. Informed consent for vaccination was obtained by the pharmacist for all individuals and\/or their parent\/legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no known conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1266"}}